Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Stefan Wöhrer"'
Autor:
Barbara Kiesewetter, Julius Lukas, Andreas Kuchar, Marius E Mayerhoefer, Berthold Streubel, Heimo Lagler, Leonhard Müllauer, Stefan Wöhrer, Julia Fischbach, Markus Raderer
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e104004 (2014)
BackgroundOrbital marginal zone B-cell lymphoma (OAML) constitutes for the most frequent diagnosis in orbital lymphoma. Relatively little data, however, have been reported in larger cohorts of patients staged in a uniform way and no therapy standard
Externí odkaz:
https://doaj.org/article/ad5fd97c7758475f8e8e1cc779e3c7dd
Autor:
Johannes Huber, Stefan Wöhrer
Jeder Mensch braucht eine andere Ernährung, eine andere Form der Bewegung, einen anderen Lebensstil und im Krankheitsfall andere Medikamente und Dosierungen. Die moderne Medizin hat das erkannt und liefert dazu jeden Tag neue, bahnbrechende Forschun
Autor:
Maria Theresa Krauth, Andreas L. Petzer, Sonja Burgstaller, Veronika Buxhofer-Ausch, Stefan Wöhrer, Christine Beham-Schmid, Günther Gastl, Alois Lang, Heinz Gisslinger, Albert Wölfler, Thamer Sliwa, Klaus Geissler, Peter Krippl
Publikováno v:
Wiener klinische Wochenschrift. 129:293-302
The entity "myelofibrosis" represents a subgroup of the Philadelphia chromosome-negative myeloproliferative neoplasms. It comprises primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. This het
Autor:
Holger Rumpold, Sonja Burgstaller, Günther Gastl, Veronika Buxhofer-Ausch, Thamer Sliwa, Klaus Geissler, Maria-Theresa Krauth, Heinz Gisslinger, Peter Krippl, Albert Wölfler, Felix Keil, Thomas Melchardt, Andreas L. Petzer, Stefan Wöhrer
Publikováno v:
Wiener klinische Wochenschrift. 130(17-18)
The oral Janus associated kinase (JAK1/2) inhibitor ruxolitinib has been available for treatment of patients with intermediate or high-risk myelofibrosis in Europe since 2012. Since its introduction, the expertise of prescribing doctors with respect
Autor:
Werner Dolak, Andreas Chott, Heimo Lagler, Andrew Wotherspoon, Barbara Kiesewetter, Markus Raderer, Leonhard Muellauer, Stefan Wöhrer
Publikováno v:
Annals of Hematology. 94:969-973
Relatively little is known about the long-term outcome of patients with Helicobacter pylori (HP)-negative gastric lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with antibiotic therapy as sole management. We have analyzed all patients
Autor:
Alexandra Böhm, Ulrich Jaeger, Nina Worel, Wolfgang R. Sperr, Marija Bojic, Hildegard T. Greinix, Thamer Sliwa, Stefan Wöhrer, Peter Kalhs, Alexander W. Hauswirth, Peter Valent, Felix Keil, Werner Rabitsch, Peter Schellongowski
Publikováno v:
European Journal of Clinical Investigation. 44:775-783
Background Allogeneic haematopoietic stem cell transplantation (HSCT) is the only curative rescue therapy for patients (pts) with chemotherapy-refractory acute leukaemia. Disease control prior to HSCT is essential for long-term disease-free survival
Autor:
David G. Kent, Keegan Rowe, Claudia Benz, Connie J. Eaves, David J.H.F. Knapp, Michael R. Copley, Stefan Wöhrer, Robert A.J. Oostendorp, Heidi Mader, Sonja Babovic
Publikováno v:
Cell Reports
Cell Reports, Vol 7, Iss 6, Pp 1956-1967 (2014)
Cell Reports, Vol 7, Iss 6, Pp 1956-1967 (2014)
Summary Hematopoietic stem cells (HSCs) are identified by their ability to sustain prolonged blood cell production in vivo, although recent evidence suggests that durable self-renewal (DSR) is shared by HSC subtypes with distinct self-perpetuating di
Autor:
Julia Fischbach, Leonhard Müllauer, Marius E. Mayerhoefer, Markus Raderer, Barbara Kiesewetter, Stefan Wöhrer, Julius Lukas, Marlene Troch
Publikováno v:
Annals of Hematology. 93:1287-1295
We have performed a retrospective analysis of all patients with extragastric mucosa-associated lymphoid tissue (MALT) lymphoma treated at our institution to compare the efficacy of first-line therapeutic modalities including surgery, radiation, syste
Autor:
Klaus Geissler, Maria-Theresa Krauth, Peter Krippl, Thomas Melchardt, Stefan Wöhrer, Albert Wölfler, Felix Keil, Sonja Burgstaller, Holger Rumpold, Günther Gastl, Andreas L. Petzer, Heinz Gisslinger, Veronika Buxhofer-Ausch, Thamer Sliwa
Publikováno v:
Wiener Klinische Wochenschrift
Summary The oral Janus associated kinase (JAK1/2) inhibitor ruxolitinib has been available for treatment of patients with intermediate or high-risk myelofibrosis in Europe since 2012. Since its introduction, the expertise of prescribing doctors with
Autor:
Keegan Rowe, Nima Aghaeepour, Claudia Benz, Stefan Wöhrer, Adrian Cortes, David G. Kent, Heidi Mader, Christopher Day, Elaine Ma, David Q. Treloar, Connie J. Eaves, Ryan R. Brinkman, Michael R. Copley
Publikováno v:
Cell Stem Cell. 10:273-283
SummaryAdult hematopoietic stem cells (HSCs) with serially transplantable activity comprise two subtypes. One shows a balanced output of mature lymphoid and myeloid cells; the other appears selectively lymphoid deficient. We now show that both of the